SOURCE: ProPhase Labs

ProPhase Labs

August 04, 2011 08:00 ET

ProPhase Labs to Release Second Quarter Results on Wednesday, August 10th

DOYLESTOWN, PA--(Marketwire - Aug 4, 2011) - ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the second quarter, ended June 30, 2011, will be released before the market opens on Wednesday, August 10, 2011. An earnings conference call will be held later that day on August 10th, at 12:00pm EDT. ProPhase Labs Chairman and CEO, Ted Karkus, and COO/CFO Robert Cuddihy will provide a company overview including a review of activities and second quarter results.

The conference call will be webcast live at at 12:00 PM (EDT) on Wednesday, August 10, 2011.

Participants may access the live call (in listen-only mode) by dialing (877) 217-6026 conference ID # 86818201. A replay of the conference call will be available for 90 days on the company website

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer and manufacturer of the Cold-EEZE® family of lozenges clinically proven to significantly reduce the severity and duration of the common cold. Cold-EEZE customers include leading national retailers, chain food, drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies. ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE lozenges and fulfill other contract manufacturing opportunities. ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion"). Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds. Phusion will formulate and test products to exploit market opportunities within ProPhase's robust OTC distribution channels. For more information visit us at

Contact Information

  • Press Only Contact:
    Jenny Miranda
    5W Public Relations
    Tel: (212) 584-4295

    Investor Relations:
    Ted Karkus
    ProPhase Labs
    Chairman of the Board, CEO
    (215) 345-0919 x0